Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, September 20, 2016
Custom Pharma Services, a full-service contract development and manufacturing organization (CDMO), has acquired a new building to expand its high containment manufacturing and development operations.
read more
Velocity Clinical Research announces today it has entered into an agreement with Global Healthcare Opportunities to be acquired from NaviMed Capital.
read more
Catalent and Stirling Ultracold have announced a partnership whereby Stirling Ultracold becomes the preferred provider of ULT storage across Catalent’s multiple business units.
read more
The Contract Network, a startup collaboration platform focused on radically accelerating contract negotiations and simplifying contract compliance, has entered into a know-how agreement with Mayo Clinic to build a solution that will simplify the ...
read more
Thursday, September 25, 2014
CEVEC Pharmaceuticals, the developer and licensor of the CAP® Technology today announced the extension of its CAP® Technology Business portfolio by offering cGMP compliant Contract Manufacturing Services.
CAP® derived clinical materials comprising ...
read more
Alexza Pharmaceuticals has updated and amended its ADASUVE® (Staccato® loxapine) commercial partnerships with Grupo Ferrer Internacional, S.A. and Teva Pharmaceutical Industries Ltd.
read more
Tuesday, November 28, 2017
Ardelyx and Kyowa Hakko Kirin announced they have entered into a license agreement that provides Kyowa Hakko Kirin with exclusive rights to develop and commercialize tenapanor.
read more
Wednesday, January 02, 2019
Propanc Biopharma announced that a cooperation agreement has been entered into between the University of Jaén and Propanc to begin the POP1 joint drug discovery program.
read more
CPhI Worldwide, organised by UBM EMEA, announces its Expert Panel for CPhI Worldwide 2015 ahead of the eagerly anticipated annual report (3rd edition) – to be released September and October 2015, in three parts. The report presents a holistic ...
read more
Charles River Laboratories International, Inc. and National University of Singapore’s (NUS) Yong Loo Lin School of Medicine (NUS Medicine), a leading medical education institution with a world-renowned medical research field of stem cell biology and ...
read more
Wednesday, September 18, 2019
Elligo Health Research is helping Jack Nathan Health patients gain exclusive access to clinical research as a care option at its Canadian Walmart clinics.
read more
Monday, September 17, 2018
PAREXEL and Datavant announced they are partnering to enhance clinical study design and operations, as well as the generation of real-world evidence.
read more
Monday, September 28, 2020
Roquette has appointed Barentz as its strategic partner for the distribution of pharmaceutical and nutraceutical products in the United States.
read more
Tuesday, October 27, 2020
Lonza announced a $93m investment in its CHI Division, a dosage form delivery partner to the biopharma and health nutrition industry.
read more
Thermo Fisher announced it has entered into an agreement with Agios to develop and commercialize a next-generation sequencing oncology companion diagnostic for ivosidenib to identify isocitrate dehydrogenase 1 mutations in cholangiocarcinoma patients...
read more